Bruker Corporation (BRKR)
NASDAQ: BRKR · IEX Real-Time Price · USD
81.48
+0.89 (1.10%)
Apr 26, 2024, 10:45 AM EDT - Market open
Bruker Revenue
In the year 2023, Bruker had annual revenue of $2.96B with 17.14% growth. Revenue in the quarter ending December 31, 2023 was $854.50M with 20.62% year-over-year growth.
Revenue (ttm)
$2.96B
Revenue Growth
+17.14%
P/S Ratio
3.74
Revenue / Employee
$305,398
Employees
9,707
Market Cap
11.28B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.96B | 433.80M | 17.14% |
Dec 31, 2022 | 2.53B | 112.80M | 4.67% |
Dec 31, 2021 | 2.42B | 430.40M | 21.66% |
Dec 31, 2020 | 1.99B | -85.10M | -4.11% |
Dec 31, 2019 | 2.07B | 177.00M | 9.34% |
Dec 31, 2018 | 1.90B | 129.70M | 7.34% |
Dec 31, 2017 | 1.77B | 154.60M | 9.59% |
Dec 31, 2016 | 1.61B | -12.50M | -0.77% |
Dec 31, 2015 | 1.62B | -185.10M | -10.23% |
Dec 31, 2014 | 1.81B | -30.50M | -1.66% |
Dec 31, 2013 | 1.84B | 48.00M | 2.68% |
Dec 31, 2012 | 1.79B | 139.70M | 8.46% |
Dec 31, 2011 | 1.65B | 346.80M | 26.58% |
Dec 31, 2010 | 1.30B | 190.40M | 17.08% |
Dec 31, 2009 | 1.11B | 7.40M | 0.67% |
Dec 31, 2008 | 1.11B | 74.70M | 7.24% |
Dec 31, 2007 | 1.03B | 181.00M | 21.26% |
Dec 31, 2006 | 851.40M | 479.15M | 128.72% |
Dec 31, 2005 | 372.25M | 15.26M | 4.28% |
Dec 31, 2004 | 356.99M | 96.31M | 36.95% |
Dec 31, 2003 | 260.68M | 40.02M | 18.14% |
Dec 31, 2002 | 220.66M | 45.38M | 25.89% |
Dec 31, 2001 | 175.28M | 98.68M | 128.82% |
Dec 31, 2000 | 76.60M | 11.91M | 18.41% |
Dec 31, 1999 | 64.69M | 22.48M | 53.27% |
Dec 31, 1998 | 42.21M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
DaVita | 12.14B |
Solventum | 8.20B |
Smith & Nephew | 5.55B |
Charles River Laboratories International | 4.13B |
Catalent | 4.10B |
Incyte | 3.70B |
Exact Sciences | 2.50B |
United Therapeutics | 2.33B |
BRKR News
- 3 hours ago - Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID Global 2024 Conference - Business Wire
- 18 hours ago - Bruker Announces Date and Time of First Quarter 2024 Earnings Release and Webcast - Business Wire
- 4 days ago - Bruker to Acquire the NanoString Business in an Asset Deal - Business Wire
- 8 days ago - Seattle biotech company NanoString to be acquired by Bruker for $392M, ending bankruptcy process - GeekWire
- 18 days ago - Bruker Introduces Novel NMR Scientific Capabilities for Structural Biology Discoveries in Membrane Proteins and Protein Aggregates - Business Wire
- 18 days ago - Bruker Advances Magnet Technology for Broader Adoption of NMR in Academic and Biopharma Research, and Process Analytical Technologies - Business Wire
- 25 days ago - Bruker Selected as ‘Company of the Year' by Instrument Business Outlook - Business Wire
- 6 weeks ago - Bruker Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO - Business Wire